Каннабиноидергическая регуляция функционального состояния сердца (часть II)

Автор: Крылатов Андрей Владимирович, Серебров Владимир Юрьевич, Ваизова Ольга Евгеньевна, Дьякова Елена Юрьевна

Журнал: Сибирский журнал клинической и экспериментальной медицины @cardiotomsk

Статья в выпуске: 4 т.32, 2017 года.

Бесплатный доступ

Экспериментальные исследования показали, что каннабиноиды вызывают гипотензию и брадикардию, которые являются следствием стимуляции каннабиноидных СВ1-рецепторов. Каннабиноид-индуцированная брадикардия является результатом симпатолитического и ваготонического действия каннабиноидов.

Каннабиноиды, сердце, вегетативная нервная система

Короткий адрес: https://sciup.org/149125190

IDR: 149125190 | DOI: 10.29001/2073-8552-2017-32-4-7-10

Список литературы Каннабиноидергическая регуляция функционального состояния сердца (часть II)

Dewey W.L., Jenkins J., O'Rourke T., Harris L.S. The effect of chronic administration of trans-.9-tetrahydrocannabinol on behavior and the cardiovascular system of dogs/Archives Internationales de Pharmacodynamie et de Therapie. 1972; 198(1): 118-131.
Domino E.F. Neropsychologic studies of marihuana. Some synthetic and natural THC derivates in animals and man/Annals of the New York Academy of Sciences. 1971; (191): 166-191.
Hollister L.E., Richards R.K., Gillespie H.K. Comparison of tetrahydrocannabinol and synhexl in man/Clinical Pharmacology and Therapeutics. 1968; 9(6): 783-791.
Malit L.A., Johnstone R.E., Bourke D.I., Kulp R.A., Klein V., Smith T.C. Intravenous.9-tetrahydrocannabinol: Effects on ventilatory control and cardiovascular dynamics/Anesthesiology. 1975; 42(6): 666-673.
Cavero I., Ertel R., Buckley J.P., Jandhyala B.S. Effects of (-)-.9transtetrahydrocannabinol on regional blood flow in anesthetized dogs/European Journal of Pharmacology. 1972; 20(3): 373-376.
Adams M.D., Chait L.D., Earnhardt J.T. Tolerance to the cardiovascular effects of.9-tetrahydrocannabinol in the rat British/Journal of Pharmacology. 1976; 56(1): 43-48.
Kaymakcalan S., Sivil S. Lack of tolerance to the bradycardic effect of.9-trans-tetrahydrocannabinol in rats/Pharmacology. 1974; 12(4-5): 290-295.
Stark P., Dews P.B. Cannabinoids. II. Cardiovascular effects/Journal of Pharmacology and Experimental Therapeutics. 1980; 214(1): 131-138.
Cavero I., Lokhandwala M.F., Buckley J.P., Jandhyala B.S. The effect of (-)-.9-trans-tetrahydrocannibinol on myocardial contractility and venous return in anesthetized dogs/European Journal of Pharmacology. 1974; 29(1): 74-82.
Lake K.D., Compton D.R., Varga K. Martin B.R., Kunos G. Cannabinoidinduced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors/Journal of Pharmacology and Experimental Therapeutics. 1997; 281(3): 1030-1037.
Vivan J.A., Kishioka S., Butelman E.R., Broadbear J., Lee K.O., Woods J.H. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A/Journal of Pharmacology and Experimental Therapeutics. 1998; 286(2): 697-703.
Krylatov A.V., Maslov L.N., Ermakov S.Yu., Lasukova O.V., Barzakh E.I., Crawfordd D., Pertwee R.G. Significance of cardiac cannabinoid receptors in regulation of cardiac rhythm, myocardial contractility, and electrophysiologic process in heart/Biology Bulletin. 2007; 34(1): 28-35.
DOI: 10.1134/S1062359007010049
AlSuleimani Y.M., Hiley C.R. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca2+ release in rat mesenteric artery endothelial cells/British Journal of Pharmacology. 2015; 172(12): 3043-3057.
DOI: 10.1111/bph.13107
Stanley C.P., Hind W.H., Tufarelli C., O'Sullivan S.E. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation/Cardiovascular Research. 2015; 107(4): 568-578.
DOI: 10.1093/cvr/cvv179
Stanley C., O'Sullivan S.E. Vascular targets for cannabinoids: animal and human studies/British Journal of Pharmacology. 2014; 171(6): 1361-178.
DOI: 10.1111/bph.12560
Vollmer R.R., Cavero I., Ertel R.J., Solomon T.A., Buckley J.P. Role of central autonomic nervous system in the hypotension and bradycardia induced by (-)-.9-trans-tetrahydrocannabinol/Journal of Pharmacy and Pharmacology. 1974; 26(3): 186-192.
Bright T.P., Farber M.O., Brown D.J., Forney R.B. Cardiopulmonary toxicity of.9-tetrahydrocannabinol in the anesthetized dog/Toxicology and Applied Pharmacology. 1975; 31(1): 100-106.
Jandhyala B.S., Hamed A.T. Pulmonary and systemic hemodynamic effects of delta9-tetrahydrocannabinol in conscious and morphine-chloralose-anesthetized dogs: anesthetic influence on drug action/European Journal of Pharmacology. 1978; 53(1): 63-68.
Vidrio H., Sanchez-Salvatori M.A., Medina M. Cardiovascular effects of (-)-11-OH-.8-tetrahydrocannabinol-dimethylheptyl in rats/Journal of Cardiovascular Pharmacology. 1996; 28(2): 332-336.
DOI: 10.1097/00005344-199608000-00022
Seagard J.L., Dean C., Patel S., Rademacher D.J., Hopp F.A., Schmeling W.T., Hillard C.J. AEA content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition/American Journal of Physiology Heart Circulation Physiology. 2004; 286(3): 992-1000.
DOI: 10.1152/ajpheart.00870.2003
Molderings G.J., Likungu J., Gothert M. Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship/Naunyn-Schmiedeberg's Archives of Pharmacology. 1999; 360(2): 157-164.
DOI: 10.1007/s002109900043
Kurihara J., Nishigaki M., Suzuki S., Okubo Y., Takata Y., Nakane S., Sugiura T., Waku K., Kato H. 2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves/Japanese Journal of Pharmacology. 2001; 87(1): 93-96.
DOI: 10.1254/jjp.87.93
Kurz C.M., Gottschalk C., Schlicker E., Kathmann M. Identification of a presynaptic cannabinoid CB1 receptor in the guineapig atrium and sequencing of the guinea-pig CB1 receptor/Journal of Physiology and Pharmacology. 2008; 59(1): 3-15.
Szabo B., Nordheim U., Niederhoffer N. Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart/Journal of Pharmacology and Experimental Therapeutics. 2001; 297(2): 819-826.
Malinowska B., Piszcz J., Koneczny B., Hryniewicz A, Schlicker E. Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors/Naunyn-Schmiedeberg's Archives of Pharmacology. 2001; 364(3): 233-241.
DOI: 10.1007/s002100100450
Gardiner S.M., March J.E., Kemp P.A., Bennett T. Complex regional haemodynamic effects of anandamide in conscious rats/British Journal of Pharmacology. 2002; 135(8): 1889-1896.
DOI: 10.1038/sj.bjp.0704649
Niederhoffer N., Szabo B. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits/Journal of Pharmacology and Experimental Therapeutics. 2000; 294(2): 707-713.

Еще

Статья научная